1,948
Views
62
CrossRef citations to date
0
Altmetric
Abstracts

North American Congress of Clinical Toxicology (NACCT) Abstracts 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Sarah Mahonski, Phil DiSalvo & Robert S. Hoffman. (2022) Comment on: “validation of a nomogram used to predict lithium concentration in overdose”. Clinical Toxicology 60:9, pages 1082-1083.
Read now
Khin Sam, Anselm Wong & Andis Graudins. (2022) Validation of a nomogram used to predict lithium concentration in overdose. Clinical Toxicology 60:7, pages 843-850.
Read now

Articles from other publishers (60)

Ari B. Filip, Christopher W. Farnsworth, Michael E. Mullins, Bridgit O. Crews & Jeffrey A. Kraut. (2023) Accuracy of a Glycerol Dehydrogenase Assay for Ethylene Glycol Detection. Journal of Medical Toxicology.
Crossref
Omid Mehrpour, Samaneh Nakhaee, Farhad Saeedi, Bahare Valizade, Erfan Lotfi & Malik Hamza Nawaz. (2023) Utility of artificial intelligence to identify antihyperglycemic agents poisoning in the USA: introducing a practical web application using National Poison Data System (NPDS). Environmental Science and Pollution Research 30:20, pages 57801-57810.
Crossref
Anastasiya Yurevna Simonova, Pavel Gennadevich Rozhkov, Mariya Vladimirovna Belova, Kapitolina Konstsntinovna Ilyashenko, Mikhail Mikhaylovich Potskhveriya, Yuriy Nikolaevich Ostapenko, Yuriy Semenovich Goldfarb, Anna Ivanovna Fetisova, Alexandr Nikanorovich Elkov & Tatyana Anatolevna Sokolova. (2021) Analysis of the toxicological situation in Moscow in the first three months of the COVID-19 pandemic. Toxicological Review 29:5, pages 49-57.
Crossref
. (2021) Multiple drugs. Reactions Weekly 1848:1, pages 295-295.
Crossref
. (2021) Metformin. Reactions Weekly 1848:1, pages 248-248.
Crossref
. (2021) Lithium overdose. Reactions Weekly 1848:1, pages 242-242.
Crossref
. (2021) Colecalciferol. Reactions Weekly 1848:1, pages 127-127.
Crossref
. (2021) Acetylcysteine. Reactions Weekly 1848:1, pages 16-16.
Crossref
. (2021) Warfarin overdose. Reactions Weekly 1847:1, pages 446-446.
Crossref
. (2021) Tizanidine overdose. Reactions Weekly 1847:1, pages 418-418.
Crossref
. (2021) Theophylline. Reactions Weekly 1847:1, pages 416-416.
Crossref
. (2021) Salbutamol abuse. Reactions Weekly 1847:1, pages 403-403.
Crossref
. (2021) Rivaroxaban overdose. Reactions Weekly 1847:1, pages 401-401.
Crossref
. (2021) Perampanel overdose. Reactions Weekly 1847:1, pages 382-382.
Crossref
. (2021) Paracetamol overdose. Reactions Weekly 1847:1, pages 375-375.
Crossref
. (2021) Paracetamol. Reactions Weekly 1847:1, pages 374-374.
Crossref
. (2021) Paracetamol. Reactions Weekly 1847:1, pages 373-373.
Crossref
. (2021) Oxycodone/paracetamol/paracetamol/diphenhydramine. Reactions Weekly 1847:1, pages 370-370.
Crossref
. (2021) Ondansetron/varenicline. Reactions Weekly 1847:1, pages 369-369.
Crossref
. (2021) Ondansetron. Reactions Weekly 1847:1, pages 368-368.
Crossref
. (2021) Ondansetron. Reactions Weekly 1847:1, pages 367-367.
Crossref
. (2021) Norepinephrine. Reactions Weekly 1847:1, pages 366-366.
Crossref
. (2021) Multiple drugs. Reactions Weekly 1847:1, pages 353-353.
Crossref
. (2021) Multiple drugs. Reactions Weekly 1847:1, pages 349-349.
Crossref
. (2021) Multiple drugs. Reactions Weekly 1847:1, pages 346-347.
Crossref
. (2021) Multiple drugs. Reactions Weekly 1847:1, pages 345-345.
Crossref
. (2021) Multiple drugs. Reactions Weekly 1847:1, pages 321-321.
Crossref
. (2021) Multiple drugs. Reactions Weekly 1847:1, pages 317-317.
Crossref
. (2021) Methylthioninium-chloride. Reactions Weekly 1847:1, pages 306-306.
Crossref
. (2021) Methotrexate. Reactions Weekly 1847:1, pages 293-293.
Crossref
. (2021) Methadone overdose. Reactions Weekly 1847:1, pages 292-292.
Crossref
. (2021) Lurasidone. Reactions Weekly 1847:1, pages 283-283.
Crossref
. (2021) Loperamide misuse and overdose. Reactions Weekly 1847:1, pages 280-280.
Crossref
. (2021) Lidocaine/epinephrine. Reactions Weekly 1847:1, pages 276-276.
Crossref
. (2021) Iron sucrose overdose. Reactions Weekly 1847:1, pages 260-260.
Crossref
. (2021) Insulin overdose. Reactions Weekly 1847:1, pages 252-252.
Crossref
. (2021) Ibuprofen overdose. Reactions Weekly 1847:1, pages 234-234.
Crossref
. (2021) Hydroxyzine. Reactions Weekly 1847:1, pages 227-227.
Crossref
. (2021) Hydromorphone. Reactions Weekly 1847:1, pages 224-224.
Crossref
. (2021) Heparin/insulin suspension isophane/protamine sulfate. Reactions Weekly 1847:1, pages 218-218.
Crossref
. (2021) Fluoxetine/propranolol/quetiapine overdose. Reactions Weekly 1847:1, pages 210-210.
Crossref
. (2021) Fentanyl/ketamine/propofol. Reactions Weekly 1847:1, pages 203-203.
Crossref
. (2021) Ethosuximide overdose. Reactions Weekly 1847:1, pages 197-197.
Crossref
. (2021) Epinephrine. Reactions Weekly 1847:1, pages 193-193.
Crossref
. (2021) Dextromethorphan overdose. Reactions Weekly 1847:1, pages 173-173.
Crossref
. (2021) Dextromethorphan overdose. Reactions Weekly 1847:1, pages 172-172.
Crossref
. (2021) Dapsone. Reactions Weekly 1847:1, pages 162-162.
Crossref
. (2021) Dapsone. Reactions Weekly 1847:1, pages 161-161.
Crossref
. (2021) Crotalidae-immune-fab-(equine). Reactions Weekly 1847:1, pages 145-145.
Crossref
. (2021) Crotalidae immune fab (equine). Reactions Weekly 1847:1, pages 144-144.
Crossref
. (2021) Ciprofloxacin. Reactions Weekly 1847:1, pages 134-134.
Crossref
. (2021) Capecitabine overdose. Reactions Weekly 1847:1, pages 116-116.
Crossref
. (2021) Bupropion overdose. Reactions Weekly 1847:1, pages 111-111.
Crossref
. (2021) Buprenorphine. Reactions Weekly 1847:1, pages 110-110.
Crossref
. (2021) Baclofen. Reactions Weekly 1847:1, pages 92-92.
Crossref
. (2021) Atropine/pilocarpine. Reactions Weekly 1847:1, pages 84-84.
Crossref
. (2021) Atropine/naloxone/quetiapine misuse. Reactions Weekly 1847:1, pages 83-83.
Crossref
. (2021) Atomoxetine overdose. Reactions Weekly 1847:1, pages 82-82.
Crossref
. (2021) Antiepileptic-drugs. Reactions Weekly 1847:1, pages 42-42.
Crossref
. (2021) Acetylcysteine/paracetamol overdose. Reactions Weekly 1847:1, pages 20-20.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.